5/15/2013

Canada has issued new regulations, effective in November, that will establish good manufacturing practice requirements for all companies that manufacture, package/label, test or import APIs. Labeling will need to ensure that APIs can be traced from the original manufacturer to the maker of the drug in dosage form.

Related Summaries